Correlation of residual disease with morphologic remission status at the end of induction 1
| Residual disease . | All patients (n = 219), n (%) . | CR (n = 188), n (%) . | PR (n = 15), n (%) . | Refractory (n = 12), n (%) . | Persistent CNS disease (n = 3), n (%) . | Not evaluable (n = 1), n (%) . |
|---|---|---|---|---|---|---|
| Yes | 67 (31) | 46 (24) | 9 (60) | 11 (92) | 1 (33) | 0 (0) |
| No | 152 (69) | 142 (76) | 6 (40) | 1 (8) | 2 (67) | 1 (100) |
| Residual disease . | All patients (n = 219), n (%) . | CR (n = 188), n (%) . | PR (n = 15), n (%) . | Refractory (n = 12), n (%) . | Persistent CNS disease (n = 3), n (%) . | Not evaluable (n = 1), n (%) . |
|---|---|---|---|---|---|---|
| Yes | 67 (31) | 46 (24) | 9 (60) | 11 (92) | 1 (33) | 0 (0) |
| No | 152 (69) | 142 (76) | 6 (40) | 1 (8) | 2 (67) | 1 (100) |
CR indicates complete remission; PR, partial response; and CNS, central nervous system.